Sichuan Provincial People's Hospital
Chengdu, Sichuan, 646000, China
NCT Number: NCT06636279
To investigate the efficiency and safety of using "Gas Bubble Technique" to reduce corneal endothelial damage in hard nucleus cataract patients.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Chengdu, Sichuan, 646000, China
The study is designed to: test the hypothesis that the "Gas Bubble Technique" is an effective method for reducing corneal endothelial damage. Describe and evaluate the effects of "Gas Bubble Technique" on a well-defined group of patients over a 1-month period following treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Inject the sterile air into the anterior chamber after the conventional cataract surgery to reduce corneal endothelial damage
Time frame: 1 week and 1 month
The endothelial cell loss (ECL) was calculated as the percentage change in ECD from preoperative to postoperative values relative to the preoperative ECD.
Time frame: 1 week and 1 month
CCT increase rates = ([postoperative CCT - preoperative CCT]/preoperative CCT) × 100%
Time frame: 1 week and 1 month
Coefficient of variation reflected polymegathism
Time frame: 1 week and 1 month
The percentage of hexagonality represented pleomorphism, indicating the ratio of hexagonal cells to cells of other shapes
Time frame: 1day, 1week, 1 month
Intraocular pressure measurement
Sichuan Provincial People's Hospital
Other
Clinical Effects of "Gas Bubble Technique" on Corneal Endothelial Recovery After Cataract Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07694375
Corneal Diseases, Corneal Endothelial Cell Loss
View Trial Details